Education
About Us
Working with TipRanks
Follow Us
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
See the Price Targets and Ratings of:
ZVSA Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$120
Buy
17042.86%
Upside
Reiterated
03/26/24
Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$120
Buy
17042.86%
Upside
Reiterated
03/26/24
Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements
Best Analysts Covering ZyVersa Therapeutics
Which Analyst Should I Follow If I Want to Buy ZVSA and Sell After:
1 Month
xxx
Success Rate
0/5 ratings generated profit
Average Return
-35.64%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -35.64% per trade.
3 Months
xxx
Success Rate
0/5 ratings generated profit
Average Return
-64.72%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -64.72% per trade.
1 Year
2 Years
xxx
Success Rate
0/5 ratings generated profit
Average Return
-95.02%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -95.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ZVSA Analyst Recommendation Trends
Rating
Dec 23
Feb 24
Mar 24
Nov 24
Jan 25
Strong Buy
4
4
6
5
4
Buy
0
0
0
0
0
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
6
5
5
Each month's total comprises the sum of three months' worth of ratings.
ZVSA Stock Forecast FAQ
What is ZVSA’s average 12-month price target, according to analysts?
Based on analyst ratings, ZyVersa Therapeutics’s 12-month average price target is 20.00.
What is ZVSA’s upside potential, based on the analysts’ average price target?
ZyVersa Therapeutics has 2757.14% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ZVSA a Buy, Sell or Hold?
ZyVersa Therapeutics has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is ZyVersa Therapeutics’s price target?
The average price target for ZyVersa Therapeutics is 20.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $20.00. The average price target represents 2757.14% Increase from the current price of $0.7.
The highest analyst price target is $20.00 ,the lowest forecast is $20.00. The average price target represents 2757.14% Increase from the current price of $0.7.
What do analysts say about ZyVersa Therapeutics?
ZyVersa Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of ZVSA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.